Advertisement
UK markets closed
  • FTSE 100

    8,275.38
    +44.33 (+0.54%)
     
  • FTSE 250

    20,730.12
    +59.25 (+0.29%)
     
  • AIM

    805.79
    +3.10 (+0.39%)
     
  • GBP/EUR

    1.1742
    -0.0007 (-0.06%)
     
  • GBP/USD

    1.2738
    +0.0006 (+0.05%)
     
  • Bitcoin GBP

    53,187.42
    +246.20 (+0.47%)
     
  • CMC Crypto 200

    1,426.24
    -2.33 (-0.16%)
     
  • S&P 500

    5,277.51
    +42.03 (+0.80%)
     
  • DOW

    38,686.32
    +574.84 (+1.51%)
     
  • CRUDE OIL

    77.18
    -0.73 (-0.94%)
     
  • GOLD FUTURES

    2,347.70
    -18.80 (-0.79%)
     
  • NIKKEI 225

    38,487.90
    +433.77 (+1.14%)
     
  • HANG SENG

    18,079.61
    -150.58 (-0.83%)
     
  • DAX

    18,497.94
    +1.15 (+0.01%)
     
  • CAC 40

    7,992.87
    +14.36 (+0.18%)
     

LENSAR, Inc. (NASDAQ:LNSR) Just Reported, And Analysts Assigned A US$8.00 Price Target

It's been a pretty great week for LENSAR, Inc. (NASDAQ:LNSR) shareholders, with its shares surging 16% to US$3.78 in the week since its latest quarterly results. It looks like the results were pretty good overall. While revenues of US$11m were in line with analyst predictions, statutory losses were much smaller than expected, with LENSAR losing US$0.19 per share. Earnings are an important time for investors, as they can track a company's performance, look at what the analysts are forecasting for next year, and see if there's been a change in sentiment towards the company. So we collected the latest post-earnings statutory consensus estimates to see what could be in store for next year.

View our latest analysis for LENSAR

earnings-and-revenue-growth
earnings-and-revenue-growth

Taking into account the latest results, the current consensus from LENSAR's twin analysts is for revenues of US$50.8m in 2024. This would reflect a notable 14% increase on its revenue over the past 12 months. Losses are forecast to narrow 5.7% to US$1.02 per share. Yet prior to the latest earnings, the analysts had been forecasting revenues of US$51.3m and losses of US$0.74 per share in 2024. So it's pretty clear the analysts have mixed opinions on LENSAR even after this update; although they reconfirmed their revenue numbers, it came at the cost of a regrettable increase in per-share losses.

ADVERTISEMENT

The consensus price target fell 33% to US$8.00per share, with the analysts clearly concerned by ballooning losses.

These estimates are interesting, but it can be useful to paint some more broad strokes when seeing how forecasts compare, both to the LENSAR's past performance and to peers in the same industry. The analysts are definitely expecting LENSAR's growth to accelerate, with the forecast 19% annualised growth to the end of 2024 ranking favourably alongside historical growth of 12% per annum over the past three years. Compare this with other companies in the same industry, which are forecast to grow their revenue 8.1% annually. Factoring in the forecast acceleration in revenue, it's pretty clear that LENSAR is expected to grow much faster than its industry.

The Bottom Line

The most important thing to take away is that the analysts increased their loss per share estimates for next year. Happily, there were no major changes to revenue forecasts, with the business still expected to grow faster than the wider industry. Furthermore, the analysts also cut their price targets, suggesting that the latest news has led to greater pessimism about the intrinsic value of the business.

Keeping that in mind, we still think that the longer term trajectory of the business is much more important for investors to consider. We have analyst estimates for LENSAR going out as far as 2026, and you can see them free on our platform here.

And what about risks? Every company has them, and we've spotted 4 warning signs for LENSAR you should know about.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.